Robert Shepard

460 total citations
18 papers, 348 citations indexed

About

Robert Shepard is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Shepard has authored 18 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Shepard's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). Robert Shepard is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). Robert Shepard collaborates with scholars based in United States, Poland and United Kingdom. Robert Shepard's co-authors include Tyvin A. Rich, Stephen T. Mosley, Emily Blood, Philip R. Greipp, S. Vincent Rajkumar, David H. Vesole, Jonathan P. Stange, Keith Stuart, Eunice S. Wang and Meir Wetzler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Robert Shepard

17 papers receiving 340 citations

Peers

Robert Shepard
Lay Cheng Lim Singapore
Andrea Zito Italy
Ayumi Fujimoto Japan
Karen Godwin United States
Omid Kooshkaki Iran
Cristiana Agen Italy
Don Benson United States
Haixia Yang China
Mohamed H. Khattab United States
Kendra M. Hasebroock United States
Lay Cheng Lim Singapore
Robert Shepard
Citations per year, relative to Robert Shepard Robert Shepard (= 1×) peers Lay Cheng Lim

Countries citing papers authored by Robert Shepard

Since Specialization
Citations

This map shows the geographic impact of Robert Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Shepard more than expected).

Fields of papers citing papers by Robert Shepard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Shepard. The network helps show where Robert Shepard may publish in the future.

Co-authorship network of co-authors of Robert Shepard

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Shepard. A scholar is included among the top collaborators of Robert Shepard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Shepard. Robert Shepard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shepard, Robert, et al.. (2023). Differential effects of transcranial current type on heart rate variability during emotion regulation in internalizing psychopathologies. Journal of Affective Disorders. 327. 7–14. 6 indexed citations
2.
Shepard, Robert, et al.. (2022). Neuromodulatory effects of transcranial electrical stimulation on emotion regulation in internalizing psychopathologies. Clinical Neurophysiology. 145. 62–70. 7 indexed citations
3.
Stange, Jonathan P., et al.. (2020). Inflexible autonomic responses to sadness predict habitual and real-world rumination: A multi-level, multi-wave study. Biological Psychology. 153. 107886–107886. 10 indexed citations
4.
5.
6.
Stange, Jonathan P., Lisanne M. Jenkins, Katie L. Bessette, et al.. (2018). Predictors of Attrition in Longitudinal Neuroimaging Research: Inhibitory Control, Head Movement, and Resting-State Functional Connectivity. Brain Connectivity. 8(9). 527–536. 6 indexed citations
7.
Shepard, Robert. (2018). Liposomal Annamycin - A New Generation Anthracycline That Overcomes MDR and Has No Cardiac Toxicity for the Second Line Treatment of R/R AML. Clinical Lymphoma Myeloma & Leukemia. 18. S197–S198. 2 indexed citations
8.
Clarke, Noel W., Robert Shepard, Stuart Spencer, & Robert H. Jones. (2015). Olaparib combined with abiraterone in patients with metastatic prostate cancer: Safety run-in from a phase II study.. Journal of Clinical Oncology. 33(15_suppl). e16026–e16026. 1 indexed citations
9.
Wetzler, Meir, Eunice S. Wang, Robert Shepard, et al.. (2013). Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 13(4). 430–434. 32 indexed citations
10.
Kvols, Larry K., et al.. (2008). Phase II proof-of-concept study of atiprimod in patients with advanced low- to intermediate-grade neuroendocrine carcinoma. Journal of Clinical Oncology. 26(15_suppl). 4611–4611. 11 indexed citations
11.
Keene, K.S., et al.. (2005). Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 62(1). 97–103. 5 indexed citations
12.
Shepard, Robert, Donna E. Levy, Jordan Berlin, et al.. (2004). Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298). Oncology. 66(4). 303–309. 26 indexed citations
13.
Rich, Tyvin A., Robert Shepard, & Stephen T. Mosley. (2004). Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy. Journal of Clinical Oncology. 22(11). 2214–2232. 174 indexed citations
14.
Rajkumar, S. Vincent, Emily Blood, David H. Vesole, Robert Shepard, & Philip R. Greipp. (2004). A randomised phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00): A trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 22(14_suppl). 6508–6508. 8 indexed citations
15.
Rajkumar, S. Vincent, Emily Blood, David H. Vesole, Robert Shepard, & Philip R. Greipp. (2004). Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group.. Blood. 104(11). 205–205. 24 indexed citations
16.
Rajkumar, S. Vincent, Emily Blood, David H. Vesole, Robert Shepard, & Philip R. Greipp. (2004). A randomised phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00): A trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 22(14_suppl). 6508–6508. 17 indexed citations
17.
Rich, Tyvin A. & Robert Shepard. (2003). COX-2 Inhibitors as Radiation Sensitizers for Upper GI Tract Cancers: Esophagus, Stomach, and Pancreas. American Journal of Clinical Oncology. 26(Supplement 2). S110–S113. 17 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lay Cheng Lim Breakdown of academic impact, for papers by Andrea Zito Breakdown of academic impact, for papers by Ayumi Fujimoto Breakdown of academic impact, for papers by Karen Godwin Breakdown of academic impact, for papers by Omid Kooshkaki Breakdown of academic impact, for papers by Cristiana Agen Breakdown of academic impact, for papers by Don Benson Breakdown of academic impact, for papers by Haixia Yang Breakdown of academic impact, for papers by Mohamed H. Khattab Breakdown of academic impact, for papers by Kendra M. Hasebroock
Rankless by CCL
2026